High-molecular weight iron dextran: A wolf in sheep's clothing?

Journal of the American Society of Nephrology

Volumn 19, Issue 5, 2008, Pages 833-834

  Rodgers, George M ^a,h   Auerbach, Michael ^b   Cella, David ^c   Chertow, Glenn M ^d   Coyne, Daniel W ^e   Glaspy, John A ^f   Henry, David H ^g  

^a UNIVERSITY OF UTAH   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d STANFORD UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC GLUCONATE; IRON DEXTRAN; ANTIANEMIC AGENT;

ANAPHYLAXIS; ANEMIA; CLINICAL PRACTICE; DRUG COST; DRUG FATALITY; DRUG INFORMATION; DRUG MONITORING; DRUG PACKAGING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; DRUG WITHDRAWAL; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEMODIALYSIS PATIENT; HUMAN; INFORMATION DISSEMINATION; IRON DEFICIENCY ANEMIA; IRON THERAPY; MOLECULAR WEIGHT; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ECONOMICS;

ANAPHYLAXIS; CHEMISTRY, PHARMACEUTICAL; DRUG COSTS; HEMATINICS; HUMANS; IRON-DEXTRAN COMPLEX; MOLECULAR WEIGHT;

EID: 44049104314     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008030255     Document Type: Editorial

References (15)

1. Case G: Maintaining iron balance with total-dose infusion of iron dextran. ANNA J 25: 65-68, 1998
2. Auerbach M, Ballard H, Glaspy J: Clinical update: intravenous iron for anemia. Lancet 369: 1502-1504, 2007
3. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J: Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 21: 378-382, 2006
4. Silverstein SB, Rodgers GM: Parenteral iron therapy options. Am J Hematol 76: 74-78, 2004
5. Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN: Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 34: 286-290, 2002
6. McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ: Adverse events in chronic hemodialysis patients receiving intravenous iron dextran: a comparison of two products. Am J Nephrol 20: 455-462, 2000
7. Fletes R, Lazarus JM, Gage J, Chertow GM: Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis 37: 743-749, 2001
8. Auerbach M, Rodgers GM: Intravenous iron. N Engl J Med 357: 93-94, 2007
9. Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H, Balan S, Barker L, Rana J: Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label randomized trial. J Clin Oncol 22: 1301-1307, 2004
10. Moniem KA, Bhandari S: Tolerability and efficacy of parenteral iron therapy in haemodialysis patients: a comparison of preparations. Trans Alt Trans Med 1: 1-7, 2007
11. Sav T, Tokgoz B, Sipahioglu MH: Is there a difference between allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail 29: 423-426, 2007
12. Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufman LR: Intravenous ferric gluconate improves response to epoetin alfa versus oral iron and no iron in anemic patients with cancer receiving chemotherapy. Oncologist 12: 231-242, 2007
13. Hedenus M, Birgegård G, Näsman P, Ahlberg L, Karlsson T, Lauri B, Lundin J, Lärfars G, Osterborg A: Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized, multicenter study. Leukemia 21: 627-632, 2007
14. Bastit L, Vandebroek A, Altintas S, et al: A randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoietin alfa administered every three weeks with and without intravenous iron in patients with chemotherapy-induced anemia. J Clin Oncol 2008 in press
15. Pedrazzoli P, Farris A, Del Prete S, et al: Randomized trial of intravenous iron supplementation in patients in with chemotherapy-related anemia without iron deficiency treated with darbepoietin alfa. J Clin Oncol 2008 in press